Related Experiment Video
Updated: May 8, 2026

Methods to Investigate the Regulatory Role of Small RNAs and Ribosomal Occupancy of Plasmodium falciparum
Published on: December 4, 2015
Recurrent Plasmodium vivax malaria due to dose-dependent primaquine resistance: a case report
Kristina Langholz Kristensen1, Ulrik Bak Dragsted
1From the Department of Internal Medicine, Roskilde Hospital , Roskilde , Denmark.
Abstract:
The ability of Plasmodium vivax to relapse is a challenge to its management. Primaquine is the only drug licensed for the eradication of hypnozoites. We report the case of a non-immune traveller, who required high dosage primaquine treatment to obtain radical cure of vivax malaria, emphasizing the importance of country-specific and weight-based dosing of primaquine.
Related Concept Videos
Diversity of Protists II
Symbiosis
Drug toxicity: Idiosyncratic Reactions
Desensitization and Tachyphylaxis
Several...
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...

